Since activation of Rho GTPases and downstream transcription factor signaling through MRTF or YAP is a common mechanism for melanoma resistance without MAPK-reactivation; therefore, we asked if Rho signaling was increased in our resistant mouse lines. Here, RHO is linked to melanoma.